| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/14/2001 | CN1284056A Anticonvulsant and sentral nervous system-active bis (fluorophenyl) alkylamides |
| 02/14/2001 | CN1283623A 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 02/14/2001 | CN1283622A 6-hydroxy-3(4-[2-(piperidine-1-group)oxyethyl group]phenoxy)-2-(4-methoxy phenyl) benzo[b] thiophene hydrochloride salt |
| 02/14/2001 | CN1283505A Prescription and process for preparing medicine to treat toothche and odontopathy |
| 02/14/2001 | CN1283489A Picking for giving out smoking and its preparing process |
| 02/14/2001 | CN1061858C Sugar for giving up smoking |
| 02/13/2001 | US6187807 Methods of use and compositions of (S) (-)-amisulpride |
| 02/13/2001 | US6187805 Indole and indoline derivatives as 5-HT6 selective ligands |
| 02/13/2001 | US6187802 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 02/13/2001 | US6187798 Heterocyclic compounds |
| 02/13/2001 | US6187793 Psychosis, schizophrenia; antiallergens |
| 02/13/2001 | US6187792 Compounds with analgesic effect |
| 02/13/2001 | US6187789 Muscle relaxants for emergency intubation and surgery |
| 02/13/2001 | US6187785 Administering hydrogenated pyrido(4,3-b)indole derivatives such as dimebolin to treat alzheimer*s disease |
| 02/13/2001 | US6187781 Corticotropin releasing factor receptor antagonists; alzheimer*s, huntington, and parkinson disease; antidepressants, anxiolytic agents |
| 02/13/2001 | US6187778 4-aminopyrrole (3, 2-D) pyrimidines as neuropeptide Y receptor antagonists |
| 02/13/2001 | US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents |
| 02/13/2001 | US6187776 Heterocyclic compounds and their use |
| 02/13/2001 | US6187770 N-substituted azaheterocyclic compounds |
| 02/13/2001 | US6187769 Benzoxazepine derivatives and their salts and medicaments containing the same |
| 02/13/2001 | US6187562 Polynucleotides encoding human sphingosine Lyase |
| 02/13/2001 | US6187309 Method for treatment of symptoms of central nervous system disorders |
| 02/13/2001 | CA2315588A1 Use of antithrombin iii for the prophylaxis and therapy of diseases |
| 02/13/2001 | CA2012876C Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances |
| 02/10/2001 | WO2001032871A2 Follistatin-related protein zfsta4 |
| 02/10/2001 | CA2389956A1 Follistatin-related protein zfsta4 |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/08/2001 | WO2001009612A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | WO2001009349A1 Gene encoding novel serine protease-like protein |
| 02/08/2001 | WO2001009346A1 Gene encoding novel adenylate kinase 3 (ak3)-like protein |
| 02/08/2001 | WO2001009323A1 Guanosine triphosphate binding protein-coupled receptors, genes thereof and production and use of the same |
| 02/08/2001 | WO2001009322A1 Guanosine triphosphate-binding protein coupled receptors, genes thereof and production and use of the same |
| 02/08/2001 | WO2001009321A1 Gene encoding novel tsp1-like protein |
| 02/08/2001 | WO2001009320A1 Gene encoding novel adp-ribosylation factor (arf)-like protein |
| 02/08/2001 | WO2001009297A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof |
| 02/08/2001 | WO2001009182A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | WO2001009178A2 Human chaperone proteins |
| 02/08/2001 | WO2001009170A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | WO2001009169A2 Cysteine protease inhibitors |
| 02/08/2001 | WO2001009156A1 HIGH AFFINITY TGFη NUCLEIC ACID LIGANDS AND INHIBITORS |
| 02/08/2001 | WO2001009142A1 Oxazinocarbazoles for the treatment of cns diseases |
| 02/08/2001 | WO2001009140A1 Thienopyranecarboxamide derivatives |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009132A1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 02/08/2001 | WO2001009131A1 Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient |
| 02/08/2001 | WO2001009126A1 Serotonergic benzothiophenes |
| 02/08/2001 | WO2001009123A1 Benzofurylpiperazine serotonin agonists |
| 02/08/2001 | WO2001009122A2 Serotonergic benzofurans |
| 02/08/2001 | WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | WO2001009116A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 02/08/2001 | WO2001009115A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
| 02/08/2001 | WO2001009111A1 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 02/08/2001 | WO2001009110A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 02/08/2001 | WO2001009106A1 Diamino-1,2,4-triazole-carboxylic and derivatives as gsk-3 inhibitors |
| 02/08/2001 | WO2001009101A1 Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance |
| 02/08/2001 | WO2001009097A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 02/08/2001 | WO2001009096A2 Potassium channel openers |
| 02/08/2001 | WO2001009090A2 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/08/2001 | WO2001008708A2 Enhanced delivery via serpin enzyme complex receptor ligands |
| 02/08/2001 | WO2001008705A1 Remedies for neurogenic pains |
| 02/08/2001 | WO2001008692A1 Xenon an nmda antagonist |
| 02/08/2001 | WO2001008685A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | WO2001008682A2 Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats |
| 02/08/2001 | WO2001008676A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 02/08/2001 | WO2001008675A1 Use of agonists of gabab receptors and pharmaceutically acceptable derivates thereof, in the therapy of maintaining nicotine abstinence-dependent patients |
| 02/08/2001 | WO2001008661A2 Opioid sustained-released formulation |
| 02/08/2001 | WO2001008635A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2000076984A3 Novel compounds, their use and preparation |
| 02/08/2001 | WO2000069456A3 Adjuvant combination formulations |
| 02/08/2001 | WO2000067700A3 Recombinant vaccine against botulinum neurotoxin |
| 02/08/2001 | WO2000064485A8 Specifically targeted catalytic antagonists and uses thereof |
| 02/08/2001 | WO2000064460A3 Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000059851A8 Derivatives of venlafaxine and methods of preparing and using the same |
| 02/08/2001 | WO2000058307A3 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 02/08/2001 | WO2000048446A3 Use of antagonists of pg-e for the treatment of neuropathic pain |
| 02/08/2001 | DE10020237A1 Verwendung von N-Anisoyl-gamma-aminobuttersäure oder p-Anissäure zur Herstellung einer pharmazeutichen Zusammensetzung Use of N-anisoyl gamma-aminobutyric acid or p-anisic acid for preparing a composition pharmazeutichen |
| 02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 02/08/2001 | CA2391766A1 C-6 ring-substituted pyrido¬1,2-a|benzimidazole derivatives usefu l in treating central nervous system disorders |
| 02/08/2001 | CA2391348A1 Enhanced delivery via serpin enzyme complex receptor |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2380837A1 High affinity tgf.beta. nucleic acid ligands and inhibitors |
| 02/08/2001 | CA2380608A1 Serotonergic benzofurans |
| 02/08/2001 | CA2380578A1 Ring opened cpis |
| 02/08/2001 | CA2380573A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain |
| 02/08/2001 | CA2380531A1 Benzofurylpiperazine serotonin agonists |
| 02/08/2001 | CA2380489A1 Modulating binding site on potassium channels used for screening |
| 02/08/2001 | CA2380428A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/08/2001 | CA2380379A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 02/08/2001 | CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | CA2379987A1 Opioid sustained-released formulation |
| 02/08/2001 | CA2379953A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 02/08/2001 | CA2379918A1 Pharmaceuticals for neuropathic pain |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/08/2001 | CA2378929A1 Serine proteases |